An original technique of transcervical intralesional vasopressin injection that allowed direct infiltration to submucous myomas under hysteroscopic control is described. Five patients with a symptomatic submucous myoma 1.5–5 cm in size scheduled for hysteroscopic myomectomy were recruited. The time required for vasopressin injection was less than 3 minutes in all cases. The time required for myomectomy ranged from 3 to 32 minutes. Four cases had no fluid absorption, whereas 1 had absorption of 1000 mL. The patient with the longest operative time and fluid absorption had multiple submucous myomas, including a large G2 myoma of 5 cm. All cases had complete excision without complication. The surgeons rated the operations as having minimal bleeding and excellent clarity. Transcervical intralesional vasopressin injection is a potentially simple, quick, and feasible method to facilitate complete resection of submucous myomas in hysteroscopic myomectomy.
Get full access to this article
View all access options for this article.
References
1.
HillardPA. Benign diseases of the female reproductive tract: Symptoms and signs. BerekJS, AdashiEY, HillardPA. Novak's Gynaecology, 12th. Baltimore: Williams & Wilkins, 1996; 331–397.
2.
LasmarRB, XinmeiZ, IndmanPD, CelesteRK, Di Spiezio SardoAet al.Feasibility of a new system of classification of submucous myomas: A multicenter study. Fertil Steril, 2011; 95:2073–2077.
LowerAM. Laparoscopic myomectomy. StuddJ. Progress in Obstetrics and Gynaecology, 15. New York: Churchill Livingstone, 2003; 381–388.
5.
NeuwirthRS, AminHKet al.Excision of submucus fibroids with hysteroscopic control. Am J Obstet Gynecol, 1976; 126:95–99.
6.
HallezJPet al.Single-stage total hysteroscopic myomectomies: Indications, techniques, and results. Fertil Steril, 1995; 63:703–708.
7.
WamstekerK, EmanuelMH, de KruifJHet al.Transcervical hysteroscopy resection of submucous fibroids for abnormal uterine bleeding: Results regarding the degree of intramural extension. Obstet Gynecol, 1993; 82:736–740.
8.
Di Spiezio SardoA, MazzonI, BramanteS, BettocchiS, BifulcoG, GuidaM, NappiCet al.Hysteroscopic myomectomy: A comprehensive review of surgical techniques. Hum Reprod Update, 2008; 14:101–119.
9.
LethabyA, VollenhovenB, SowterMet al.Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev, 2001; 2:CD000547.
10.
MuziiL, BoniT, BellatiF, MaranaR, RuggieroA, ZulloMA, AngioliR, PaniciPBet al.GnRH analogue treatment before hysteroscopic resection of submucous myomas: A prospective, randomized, multicenter study. Fert Steril, 2010; 94:1496–1499.
11.
FedeleL, VercelliniP. Bianchi S, Brioschi D, Dorta M, et al. Treatment with GnRH agonists before myomectomy and the risk of short-term fibroid recurrence. Br J Obstet Gynaecol, 1990; 97:393–396.
12.
CampoS, CampoV, GambadauroPet al.Short-term and long-term results of resectoscopic myomectomy with and without pretreatment with GnRH analogs in premenopausal women. Acta Obstet Gynecol Scand, 2005; 84:756–760.
13.
KongnyuyEJ, Van Den BroekN, WiysongeCSet al.A systemic review of randomized controlled trials to reduce hemorrhage during myomectomy for uterine fibroids. Int J Gynecol Obstet, 2008; 100:4–9.
14.
CorsonSL, BrooksPG, SerdenSP, BatzerFR, GocialBet al.Effects of vasopressin administration during hysteroscopic surgery. J Reprod Med, 1994; 39:419–423.
15.
PhillipsDR, NathansonHG, MilimSJ, HaselkornJS, KhapraA, RossPLet al.The effect of dilute vasopressin solution on blood loss during operative hysteroscopy: A randomized controlled trial. Obstet Gynecol, 1996; 88:761–766.
16.
Van DongenH, EmanuelMH, SmeetsMJ, TrimbosB, JansenFWet al.Follow-up after incomplete hysteroscopic removal of uterine fibroids. Acta Obstet Gynecol Scand, 2006; 85:1463–1467.
17.
EmanuelMH, HartA, WamstekerK, LammesFet al.An analysis of fluid loss during transcervical resection of submucous myomas. Fertil Steril, 1997; 68:881–886.
18.
ParazziniF, VercelliniP, De GiorgiO, PesoleA, RicciE, CrosignaniPGet al.Efficacy of preoperative medical treatment in facilitating hysteroscopic endometrial ablation, myomectomy and metroplasty: Literature review. Hum Reprod, 1998; 13:2592–2597.
19.
PerinoA, ChianchianoN, PetronioM, CittadiniEet al.Role of leuprolide acetate depot in hysteroscopic surgery: A controlled study. Fertil Steril, 1993; 59:507–510.
20.
DonnezJ, GillerotS, BourgonjonD, ClerckxF, NisolleMet al.Neodymium: YAG laser hysteroscopy in large submucous fibroids. Fertil Steril, 1990; 54:999–1003.
21.
IndmanPDet al.Hysteroscopic treatment of menorrhagia associated with uterine leiofibroids. Obstet Gynecol, 1993; 81:716–720.
22.
CamanniM, BoninoL, DelpianoM, FerreroB, MigliarettiG, DeltettoFet al.Hysteroscopic management of large symptomatic submucous uterine myomas. J Minim Invasive Gynecol, 2010; 17:59–65.
23.
BettocchiS, Di Spiezio SardoA, CeciO, NappiL, GuidaM, GrecoE, PintoL, CamporialeAL, NappiCet al.A new hysteroscopic technique for the preparation of partially intramural myomas in office setting (OPPIuM technique): A pilot study. J Minim Invasive Gynecol, 2009; 16:748–754.
24.
HamerlynchTWO, DietzV, SchootBCet al.Clinical implementation of the hysteroscopic morcellator for removal of intrauterine myomas and polyps. A retrospective descriptive study. Gynecol Surg, 2011; 8:193–193.
25.
MurakamiT, TachibanaM, HoshiaiT, OzawaY, TeradaY, OkamuraKet al.Successful strategy for the hysteroscopic myomectomy of a submucous myoma arising from the uterine fundus. Fertil Steril, 2006; 86:1513.e19–e22.
